Crystal-induced oligoarthritis triggered by pembrolizumab, an immune checkpoint inhibitor.

Subjects

Subjects :

*ARTHRITIS
*PEMBROLIZUMAB
*IMMUNE response
*MELANOMA
*DRUG efficacy
*DRUG side effects
*THERAPEUTIC use of monoclonal antibodies
*CANCER invasiveness
*CHONDROCALCINOSIS
*LONGITUDINAL method
*MONOCLONAL antibodies
*RISK assessment
*SKIN tumors
*TUMOR classification

Details

Language :

English

ISSN :

1297319X

Volume :

85

Issue :

5

Database :

Academic Search Index

Journal :

Joint Bone Spine

Publication Type :

Academic Journal

Accession number :

132096748

Full Text :

https://doi.org/10.1016/j.jbspin.2018.01.009